Cytek Biosciences, Inc.
CTKB
Revenue
46.62M
▲1.76M▲3.92%
3 Months ChangeAssets
483.73M
▼-8.34M▼-1.70%
3 Months ChangeLiabilities
94.60M
▼-4.85M▼-4.88%
3 Months ChangeFree Cash Flow
3.39M
▲1.04M▲44.07%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-12
Form 8-K
ID: 0001193125-24-217558
2024-08-06
Form 10-Q
ID: 0001628280-24-035264
2024-08-06
Form 8-K
ID: 0001193125-24-194907
2024-06-11
Form 8-K
ID: 0001193125-24-159094
2024-05-08
Form 10-Q
ID: 0001628280-24-021723
2024-05-08
Form 8-K
ID: 0001193125-24-134238
2024-03-19
Form 8-K
ID: 0001193125-24-071467
2024-03-01
Form 8-K
ID: 0001193125-24-054312
2024-02-27
Form 8-K
ID: 0001193125-24-046891
2024-01-09
Form 8-K
ID: 0001193125-24-004805